Medical Care
Global Pediatric Psoriasis Treatment Market Research Report 2025
- May 12, 25
- ID: 234908
- Pages: 100
- Figures: 99
- Views: 5
The global market for Pediatric Psoriasis Treatment was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Pediatric psoriasis is a chronic, relapsing, immune, systemic skin disease that occurs in children (age < 18 years) and is induced by a combination of genetic and environmental factors (such as infection, etc.). The clinical manifestations of psoriasis in children are complex, and there are great differences in types. Due to the special physiological characteristics of children, more attention should be paid to safety in treatment. Compared with adults, the treatment of psoriasis in children is more limited and challenging, such as the ideal therapeutic dose of systemic drugs, adverse reactions caused by long-term treatment, the choice of combination drugs, and the conversion of drugs have not yet been clarified. Many medications, both topical and systemic, are not approved for the treatment of psoriasis in children.
Increase in biologics R&D activities, rising prevalence of childhood psoriasis, continuous advancement in pharmaceutical technology and comprehensive research, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth in revenue for the pediatric psoriasis treatment market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pediatric Psoriasis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Psoriasis Treatment.
The Pediatric Psoriasis Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Psoriasis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Psoriasis Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AbbVie
Amgen
Johnson and Johnson
Novartis AG
Eli Lilly and Company
AstraZeneca
Celgene Corporation
UCB
Merck
Boehringer Ingelheim
LEO Pharma
Qingdao Vland Biotech
Yunnan Botanee Bio-Technology
Furen Group
Jiangsu Kanion Pharmaceutical
Tianjin Pacific Pharmaceutical
Segment by Type
Topical Treatment
Systemic Treatment
Segment by Application
Psoriasis Vulgaris
Pustular Psoriasis
Erythrodermic Psoriasis
Arthropathic Psoriasis
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pediatric Psoriasis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pediatric Psoriasis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pediatric psoriasis is a chronic, relapsing, immune, systemic skin disease that occurs in children (age < 18 years) and is induced by a combination of genetic and environmental factors (such as infection, etc.). The clinical manifestations of psoriasis in children are complex, and there are great differences in types. Due to the special physiological characteristics of children, more attention should be paid to safety in treatment. Compared with adults, the treatment of psoriasis in children is more limited and challenging, such as the ideal therapeutic dose of systemic drugs, adverse reactions caused by long-term treatment, the choice of combination drugs, and the conversion of drugs have not yet been clarified. Many medications, both topical and systemic, are not approved for the treatment of psoriasis in children.
Increase in biologics R&D activities, rising prevalence of childhood psoriasis, continuous advancement in pharmaceutical technology and comprehensive research, and continuous regulation across the biopharmaceutical industry are the key factors driving the growth in revenue for the pediatric psoriasis treatment market.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pediatric Psoriasis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Psoriasis Treatment.
The Pediatric Psoriasis Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pediatric Psoriasis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Psoriasis Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
AbbVie
Amgen
Johnson and Johnson
Novartis AG
Eli Lilly and Company
AstraZeneca
Celgene Corporation
UCB
Merck
Boehringer Ingelheim
LEO Pharma
Qingdao Vland Biotech
Yunnan Botanee Bio-Technology
Furen Group
Jiangsu Kanion Pharmaceutical
Tianjin Pacific Pharmaceutical
Segment by Type
Topical Treatment
Systemic Treatment
Segment by Application
Psoriasis Vulgaris
Pustular Psoriasis
Erythrodermic Psoriasis
Arthropathic Psoriasis
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pediatric Psoriasis Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pediatric Psoriasis Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Pediatric Psoriasis Treatment Market Overview
1.1 Product Definition
1.2 Pediatric Psoriasis Treatment by Type
1.2.1 Global Pediatric Psoriasis Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Topical Treatment
1.2.3 Systemic Treatment
1.3 Pediatric Psoriasis Treatment by Application
1.3.1 Global Pediatric Psoriasis Treatment Market Value by Application (2024 VS 2031)
1.3.2 Psoriasis Vulgaris
1.3.3 Pustular Psoriasis
1.3.4 Erythrodermic Psoriasis
1.3.5 Arthropathic Psoriasis
1.4 Global Pediatric Psoriasis Treatment Market Size Estimates and Forecasts
1.4.1 Global Pediatric Psoriasis Treatment Revenue 2020-2031
1.4.2 Global Pediatric Psoriasis Treatment Sales 2020-2031
1.4.3 Global Pediatric Psoriasis Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pediatric Psoriasis Treatment Market Competition by Manufacturers
2.1 Global Pediatric Psoriasis Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pediatric Psoriasis Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pediatric Psoriasis Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pediatric Psoriasis Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pediatric Psoriasis Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pediatric Psoriasis Treatment, Product Type & Application
2.7 Global Key Manufacturers of Pediatric Psoriasis Treatment, Date of Enter into This Industry
2.8 Global Pediatric Psoriasis Treatment Market Competitive Situation and Trends
2.8.1 Global Pediatric Psoriasis Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pediatric Psoriasis Treatment Players Market Share by Revenue
2.8.3 Global Pediatric Psoriasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pediatric Psoriasis Treatment Market Scenario by Region
3.1 Global Pediatric Psoriasis Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pediatric Psoriasis Treatment Sales by Region: 2020-2031
3.2.1 Global Pediatric Psoriasis Treatment Sales by Region: 2020-2025
3.2.2 Global Pediatric Psoriasis Treatment Sales by Region: 2026-2031
3.3 Global Pediatric Psoriasis Treatment Revenue by Region: 2020-2031
3.3.1 Global Pediatric Psoriasis Treatment Revenue by Region: 2020-2025
3.3.2 Global Pediatric Psoriasis Treatment Revenue by Region: 2026-2031
3.4 North America Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.4.1 North America Pediatric Psoriasis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pediatric Psoriasis Treatment Sales by Country (2020-2031)
3.4.3 North America Pediatric Psoriasis Treatment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.5.1 Europe Pediatric Psoriasis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pediatric Psoriasis Treatment Sales by Country (2020-2031)
3.5.3 Europe Pediatric Psoriasis Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Psoriasis Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Pediatric Psoriasis Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pediatric Psoriasis Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Pediatric Psoriasis Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.7.1 Latin America Pediatric Psoriasis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pediatric Psoriasis Treatment Sales by Country (2020-2031)
3.7.3 Latin America Pediatric Psoriasis Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Psoriasis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pediatric Psoriasis Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pediatric Psoriasis Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pediatric Psoriasis Treatment Sales by Type (2020-2031)
4.1.1 Global Pediatric Psoriasis Treatment Sales by Type (2020-2025)
4.1.2 Global Pediatric Psoriasis Treatment Sales by Type (2026-2031)
4.1.3 Global Pediatric Psoriasis Treatment Sales Market Share by Type (2020-2031)
4.2 Global Pediatric Psoriasis Treatment Revenue by Type (2020-2031)
4.2.1 Global Pediatric Psoriasis Treatment Revenue by Type (2020-2025)
4.2.2 Global Pediatric Psoriasis Treatment Revenue by Type (2026-2031)
4.2.3 Global Pediatric Psoriasis Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Pediatric Psoriasis Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pediatric Psoriasis Treatment Sales by Application (2020-2031)
5.1.1 Global Pediatric Psoriasis Treatment Sales by Application (2020-2025)
5.1.2 Global Pediatric Psoriasis Treatment Sales by Application (2026-2031)
5.1.3 Global Pediatric Psoriasis Treatment Sales Market Share by Application (2020-2031)
5.2 Global Pediatric Psoriasis Treatment Revenue by Application (2020-2031)
5.2.1 Global Pediatric Psoriasis Treatment Revenue by Application (2020-2025)
5.2.2 Global Pediatric Psoriasis Treatment Revenue by Application (2026-2031)
5.2.3 Global Pediatric Psoriasis Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Pediatric Psoriasis Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Pediatric Psoriasis Treatment Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Pediatric Psoriasis Treatment Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Company Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson and Johnson Pediatric Psoriasis Treatment Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Company Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis AG Pediatric Psoriasis Treatment Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Eli Lilly and Company
6.5.1 Eli Lilly and Company Company Information
6.5.2 Eli Lilly and Company Description and Business Overview
6.5.3 Eli Lilly and Company Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eli Lilly and Company Pediatric Psoriasis Treatment Product Portfolio
6.5.5 Eli Lilly and Company Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AstraZeneca Pediatric Psoriasis Treatment Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Celgene Corporation
6.7.1 Celgene Corporation Company Information
6.7.2 Celgene Corporation Description and Business Overview
6.7.3 Celgene Corporation Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Celgene Corporation Pediatric Psoriasis Treatment Product Portfolio
6.7.5 Celgene Corporation Recent Developments/Updates
6.8 UCB
6.8.1 UCB Company Information
6.8.2 UCB Description and Business Overview
6.8.3 UCB Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 UCB Pediatric Psoriasis Treatment Product Portfolio
6.8.5 UCB Recent Developments/Updates
6.9 Merck
6.9.1 Merck Company Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Merck Pediatric Psoriasis Treatment Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Company Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Boehringer Ingelheim Pediatric Psoriasis Treatment Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
6.11 LEO Pharma
6.11.1 LEO Pharma Company Information
6.11.2 LEO Pharma Description and Business Overview
6.11.3 LEO Pharma Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 LEO Pharma Pediatric Psoriasis Treatment Product Portfolio
6.11.5 LEO Pharma Recent Developments/Updates
6.12 Qingdao Vland Biotech
6.12.1 Qingdao Vland Biotech Company Information
6.12.2 Qingdao Vland Biotech Description and Business Overview
6.12.3 Qingdao Vland Biotech Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Qingdao Vland Biotech Pediatric Psoriasis Treatment Product Portfolio
6.12.5 Qingdao Vland Biotech Recent Developments/Updates
6.13 Yunnan Botanee Bio-Technology
6.13.1 Yunnan Botanee Bio-Technology Company Information
6.13.2 Yunnan Botanee Bio-Technology Description and Business Overview
6.13.3 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Product Portfolio
6.13.5 Yunnan Botanee Bio-Technology Recent Developments/Updates
6.14 Furen Group
6.14.1 Furen Group Company Information
6.14.2 Furen Group Description and Business Overview
6.14.3 Furen Group Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Furen Group Pediatric Psoriasis Treatment Product Portfolio
6.14.5 Furen Group Recent Developments/Updates
6.15 Jiangsu Kanion Pharmaceutical
6.15.1 Jiangsu Kanion Pharmaceutical Company Information
6.15.2 Jiangsu Kanion Pharmaceutical Description and Business Overview
6.15.3 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Product Portfolio
6.15.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates
6.16 Tianjin Pacific Pharmaceutical
6.16.1 Tianjin Pacific Pharmaceutical Company Information
6.16.2 Tianjin Pacific Pharmaceutical Description and Business Overview
6.16.3 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Product Portfolio
6.16.5 Tianjin Pacific Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Psoriasis Treatment Industry Chain Analysis
7.2 Pediatric Psoriasis Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Psoriasis Treatment Production Mode & Process Analysis
7.4 Pediatric Psoriasis Treatment Sales and Marketing
7.4.1 Pediatric Psoriasis Treatment Sales Channels
7.4.2 Pediatric Psoriasis Treatment Distributors
7.5 Pediatric Psoriasis Treatment Customer Analysis
8 Pediatric Psoriasis Treatment Market Dynamics
8.1 Pediatric Psoriasis Treatment Industry Trends
8.2 Pediatric Psoriasis Treatment Market Drivers
8.3 Pediatric Psoriasis Treatment Market Challenges
8.4 Pediatric Psoriasis Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Pediatric Psoriasis Treatment by Type
1.2.1 Global Pediatric Psoriasis Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Topical Treatment
1.2.3 Systemic Treatment
1.3 Pediatric Psoriasis Treatment by Application
1.3.1 Global Pediatric Psoriasis Treatment Market Value by Application (2024 VS 2031)
1.3.2 Psoriasis Vulgaris
1.3.3 Pustular Psoriasis
1.3.4 Erythrodermic Psoriasis
1.3.5 Arthropathic Psoriasis
1.4 Global Pediatric Psoriasis Treatment Market Size Estimates and Forecasts
1.4.1 Global Pediatric Psoriasis Treatment Revenue 2020-2031
1.4.2 Global Pediatric Psoriasis Treatment Sales 2020-2031
1.4.3 Global Pediatric Psoriasis Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pediatric Psoriasis Treatment Market Competition by Manufacturers
2.1 Global Pediatric Psoriasis Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pediatric Psoriasis Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pediatric Psoriasis Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pediatric Psoriasis Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pediatric Psoriasis Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pediatric Psoriasis Treatment, Product Type & Application
2.7 Global Key Manufacturers of Pediatric Psoriasis Treatment, Date of Enter into This Industry
2.8 Global Pediatric Psoriasis Treatment Market Competitive Situation and Trends
2.8.1 Global Pediatric Psoriasis Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pediatric Psoriasis Treatment Players Market Share by Revenue
2.8.3 Global Pediatric Psoriasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pediatric Psoriasis Treatment Market Scenario by Region
3.1 Global Pediatric Psoriasis Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pediatric Psoriasis Treatment Sales by Region: 2020-2031
3.2.1 Global Pediatric Psoriasis Treatment Sales by Region: 2020-2025
3.2.2 Global Pediatric Psoriasis Treatment Sales by Region: 2026-2031
3.3 Global Pediatric Psoriasis Treatment Revenue by Region: 2020-2031
3.3.1 Global Pediatric Psoriasis Treatment Revenue by Region: 2020-2025
3.3.2 Global Pediatric Psoriasis Treatment Revenue by Region: 2026-2031
3.4 North America Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.4.1 North America Pediatric Psoriasis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pediatric Psoriasis Treatment Sales by Country (2020-2031)
3.4.3 North America Pediatric Psoriasis Treatment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.5.1 Europe Pediatric Psoriasis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pediatric Psoriasis Treatment Sales by Country (2020-2031)
3.5.3 Europe Pediatric Psoriasis Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pediatric Psoriasis Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Pediatric Psoriasis Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pediatric Psoriasis Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Pediatric Psoriasis Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.7.1 Latin America Pediatric Psoriasis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pediatric Psoriasis Treatment Sales by Country (2020-2031)
3.7.3 Latin America Pediatric Psoriasis Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Pediatric Psoriasis Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Pediatric Psoriasis Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pediatric Psoriasis Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pediatric Psoriasis Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pediatric Psoriasis Treatment Sales by Type (2020-2031)
4.1.1 Global Pediatric Psoriasis Treatment Sales by Type (2020-2025)
4.1.2 Global Pediatric Psoriasis Treatment Sales by Type (2026-2031)
4.1.3 Global Pediatric Psoriasis Treatment Sales Market Share by Type (2020-2031)
4.2 Global Pediatric Psoriasis Treatment Revenue by Type (2020-2031)
4.2.1 Global Pediatric Psoriasis Treatment Revenue by Type (2020-2025)
4.2.2 Global Pediatric Psoriasis Treatment Revenue by Type (2026-2031)
4.2.3 Global Pediatric Psoriasis Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Pediatric Psoriasis Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pediatric Psoriasis Treatment Sales by Application (2020-2031)
5.1.1 Global Pediatric Psoriasis Treatment Sales by Application (2020-2025)
5.1.2 Global Pediatric Psoriasis Treatment Sales by Application (2026-2031)
5.1.3 Global Pediatric Psoriasis Treatment Sales Market Share by Application (2020-2031)
5.2 Global Pediatric Psoriasis Treatment Revenue by Application (2020-2031)
5.2.1 Global Pediatric Psoriasis Treatment Revenue by Application (2020-2025)
5.2.2 Global Pediatric Psoriasis Treatment Revenue by Application (2026-2031)
5.2.3 Global Pediatric Psoriasis Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Pediatric Psoriasis Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie
6.1.1 AbbVie Company Information
6.1.2 AbbVie Description and Business Overview
6.1.3 AbbVie Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie Pediatric Psoriasis Treatment Product Portfolio
6.1.5 AbbVie Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Amgen Pediatric Psoriasis Treatment Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Johnson and Johnson
6.3.1 Johnson and Johnson Company Information
6.3.2 Johnson and Johnson Description and Business Overview
6.3.3 Johnson and Johnson Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson and Johnson Pediatric Psoriasis Treatment Product Portfolio
6.3.5 Johnson and Johnson Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Company Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis AG Pediatric Psoriasis Treatment Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Eli Lilly and Company
6.5.1 Eli Lilly and Company Company Information
6.5.2 Eli Lilly and Company Description and Business Overview
6.5.3 Eli Lilly and Company Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eli Lilly and Company Pediatric Psoriasis Treatment Product Portfolio
6.5.5 Eli Lilly and Company Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Company Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 AstraZeneca Pediatric Psoriasis Treatment Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
6.7 Celgene Corporation
6.7.1 Celgene Corporation Company Information
6.7.2 Celgene Corporation Description and Business Overview
6.7.3 Celgene Corporation Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Celgene Corporation Pediatric Psoriasis Treatment Product Portfolio
6.7.5 Celgene Corporation Recent Developments/Updates
6.8 UCB
6.8.1 UCB Company Information
6.8.2 UCB Description and Business Overview
6.8.3 UCB Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 UCB Pediatric Psoriasis Treatment Product Portfolio
6.8.5 UCB Recent Developments/Updates
6.9 Merck
6.9.1 Merck Company Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Merck Pediatric Psoriasis Treatment Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Company Information
6.10.2 Boehringer Ingelheim Description and Business Overview
6.10.3 Boehringer Ingelheim Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Boehringer Ingelheim Pediatric Psoriasis Treatment Product Portfolio
6.10.5 Boehringer Ingelheim Recent Developments/Updates
6.11 LEO Pharma
6.11.1 LEO Pharma Company Information
6.11.2 LEO Pharma Description and Business Overview
6.11.3 LEO Pharma Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 LEO Pharma Pediatric Psoriasis Treatment Product Portfolio
6.11.5 LEO Pharma Recent Developments/Updates
6.12 Qingdao Vland Biotech
6.12.1 Qingdao Vland Biotech Company Information
6.12.2 Qingdao Vland Biotech Description and Business Overview
6.12.3 Qingdao Vland Biotech Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Qingdao Vland Biotech Pediatric Psoriasis Treatment Product Portfolio
6.12.5 Qingdao Vland Biotech Recent Developments/Updates
6.13 Yunnan Botanee Bio-Technology
6.13.1 Yunnan Botanee Bio-Technology Company Information
6.13.2 Yunnan Botanee Bio-Technology Description and Business Overview
6.13.3 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Product Portfolio
6.13.5 Yunnan Botanee Bio-Technology Recent Developments/Updates
6.14 Furen Group
6.14.1 Furen Group Company Information
6.14.2 Furen Group Description and Business Overview
6.14.3 Furen Group Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Furen Group Pediatric Psoriasis Treatment Product Portfolio
6.14.5 Furen Group Recent Developments/Updates
6.15 Jiangsu Kanion Pharmaceutical
6.15.1 Jiangsu Kanion Pharmaceutical Company Information
6.15.2 Jiangsu Kanion Pharmaceutical Description and Business Overview
6.15.3 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Product Portfolio
6.15.5 Jiangsu Kanion Pharmaceutical Recent Developments/Updates
6.16 Tianjin Pacific Pharmaceutical
6.16.1 Tianjin Pacific Pharmaceutical Company Information
6.16.2 Tianjin Pacific Pharmaceutical Description and Business Overview
6.16.3 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Product Portfolio
6.16.5 Tianjin Pacific Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pediatric Psoriasis Treatment Industry Chain Analysis
7.2 Pediatric Psoriasis Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pediatric Psoriasis Treatment Production Mode & Process Analysis
7.4 Pediatric Psoriasis Treatment Sales and Marketing
7.4.1 Pediatric Psoriasis Treatment Sales Channels
7.4.2 Pediatric Psoriasis Treatment Distributors
7.5 Pediatric Psoriasis Treatment Customer Analysis
8 Pediatric Psoriasis Treatment Market Dynamics
8.1 Pediatric Psoriasis Treatment Industry Trends
8.2 Pediatric Psoriasis Treatment Market Drivers
8.3 Pediatric Psoriasis Treatment Market Challenges
8.4 Pediatric Psoriasis Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pediatric Psoriasis Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pediatric Psoriasis Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Pediatric Psoriasis Treatment Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pediatric Psoriasis Treatment Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Pediatric Psoriasis Treatment Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Pediatric Psoriasis Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Pediatric Psoriasis Treatment Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Pediatric Psoriasis Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Pediatric Psoriasis Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pediatric Psoriasis Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pediatric Psoriasis Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Pediatric Psoriasis Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pediatric Psoriasis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Psoriasis Treatment as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pediatric Psoriasis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Pediatric Psoriasis Treatment Sales by Region (2020-2025) & (K Units)
Table 18. Global Pediatric Psoriasis Treatment Sales Market Share by Region (2020-2025)
Table 19. Global Pediatric Psoriasis Treatment Sales by Region (2026-2031) & (K Units)
Table 20. Global Pediatric Psoriasis Treatment Sales Market Share by Region (2026-2031)
Table 21. Global Pediatric Psoriasis Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Pediatric Psoriasis Treatment Revenue Market Share by Region (2020-2025)
Table 23. Global Pediatric Psoriasis Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Pediatric Psoriasis Treatment Revenue Market Share by Region (2026-2031)
Table 25. North America Pediatric Psoriasis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Pediatric Psoriasis Treatment Sales by Country (2020-2025) & (K Units)
Table 27. North America Pediatric Psoriasis Treatment Sales by Country (2026-2031) & (K Units)
Table 28. North America Pediatric Psoriasis Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Pediatric Psoriasis Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Pediatric Psoriasis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Pediatric Psoriasis Treatment Sales by Country (2020-2025) & (K Units)
Table 32. Europe Pediatric Psoriasis Treatment Sales by Country (2026-2031) & (K Units)
Table 33. Europe Pediatric Psoriasis Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Pediatric Psoriasis Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Pediatric Psoriasis Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Pediatric Psoriasis Treatment Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Pediatric Psoriasis Treatment Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Pediatric Psoriasis Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Pediatric Psoriasis Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pediatric Psoriasis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Pediatric Psoriasis Treatment Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Pediatric Psoriasis Treatment Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Pediatric Psoriasis Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pediatric Psoriasis Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Pediatric Psoriasis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Pediatric Psoriasis Treatment Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Pediatric Psoriasis Treatment Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Pediatric Psoriasis Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Pediatric Psoriasis Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Pediatric Psoriasis Treatment Sales (K Units) by Type (2020-2025)
Table 51. Global Pediatric Psoriasis Treatment Sales (K Units) by Type (2026-2031)
Table 52. Global Pediatric Psoriasis Treatment Sales Market Share by Type (2020-2025)
Table 53. Global Pediatric Psoriasis Treatment Sales Market Share by Type (2026-2031)
Table 54. Global Pediatric Psoriasis Treatment Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Pediatric Psoriasis Treatment Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Pediatric Psoriasis Treatment Revenue Market Share by Type (2020-2025)
Table 57. Global Pediatric Psoriasis Treatment Revenue Market Share by Type (2026-2031)
Table 58. Global Pediatric Psoriasis Treatment Price (US$/Unit) by Type (2020-2025)
Table 59. Global Pediatric Psoriasis Treatment Price (US$/Unit) by Type (2026-2031)
Table 60. Global Pediatric Psoriasis Treatment Sales (K Units) by Application (2020-2025)
Table 61. Global Pediatric Psoriasis Treatment Sales (K Units) by Application (2026-2031)
Table 62. Global Pediatric Psoriasis Treatment Sales Market Share by Application (2020-2025)
Table 63. Global Pediatric Psoriasis Treatment Sales Market Share by Application (2026-2031)
Table 64. Global Pediatric Psoriasis Treatment Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Pediatric Psoriasis Treatment Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Pediatric Psoriasis Treatment Revenue Market Share by Application (2020-2025)
Table 67. Global Pediatric Psoriasis Treatment Revenue Market Share by Application (2026-2031)
Table 68. Global Pediatric Psoriasis Treatment Price (US$/Unit) by Application (2020-2025)
Table 69. Global Pediatric Psoriasis Treatment Price (US$/Unit) by Application (2026-2031)
Table 70. AbbVie Company Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. AbbVie Pediatric Psoriasis Treatment Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Amgen Company Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Amgen Pediatric Psoriasis Treatment Product
Table 79. Amgen Recent Developments/Updates
Table 80. Johnson and Johnson Company Information
Table 81. Johnson and Johnson Description and Business Overview
Table 82. Johnson and Johnson Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Johnson and Johnson Pediatric Psoriasis Treatment Product
Table 84. Johnson and Johnson Recent Developments/Updates
Table 85. Novartis AG Company Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Novartis AG Pediatric Psoriasis Treatment Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. Eli Lilly and Company Company Information
Table 91. Eli Lilly and Company Description and Business Overview
Table 92. Eli Lilly and Company Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Eli Lilly and Company Pediatric Psoriasis Treatment Product
Table 94. Eli Lilly and Company Recent Developments/Updates
Table 95. AstraZeneca Company Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. AstraZeneca Pediatric Psoriasis Treatment Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. Celgene Corporation Company Information
Table 101. Celgene Corporation Description and Business Overview
Table 102. Celgene Corporation Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Celgene Corporation Pediatric Psoriasis Treatment Product
Table 104. Celgene Corporation Recent Developments/Updates
Table 105. UCB Company Information
Table 106. UCB Description and Business Overview
Table 107. UCB Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. UCB Pediatric Psoriasis Treatment Product
Table 109. UCB Recent Developments/Updates
Table 110. Merck Company Information
Table 111. Merck Description and Business Overview
Table 112. Merck Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Merck Pediatric Psoriasis Treatment Product
Table 114. Merck Recent Developments/Updates
Table 115. Boehringer Ingelheim Company Information
Table 116. Boehringer Ingelheim Description and Business Overview
Table 117. Boehringer Ingelheim Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Boehringer Ingelheim Pediatric Psoriasis Treatment Product
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. LEO Pharma Company Information
Table 121. LEO Pharma Description and Business Overview
Table 122. LEO Pharma Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. LEO Pharma Pediatric Psoriasis Treatment Product
Table 124. LEO Pharma Recent Developments/Updates
Table 125. Qingdao Vland Biotech Company Information
Table 126. Qingdao Vland Biotech Description and Business Overview
Table 127. Qingdao Vland Biotech Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Qingdao Vland Biotech Pediatric Psoriasis Treatment Product
Table 129. Qingdao Vland Biotech Recent Developments/Updates
Table 130. Yunnan Botanee Bio-Technology Company Information
Table 131. Yunnan Botanee Bio-Technology Description and Business Overview
Table 132. Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Product
Table 134. Yunnan Botanee Bio-Technology Recent Developments/Updates
Table 135. Furen Group Company Information
Table 136. Furen Group Description and Business Overview
Table 137. Furen Group Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Furen Group Pediatric Psoriasis Treatment Product
Table 139. Furen Group Recent Developments/Updates
Table 140. Jiangsu Kanion Pharmaceutical Company Information
Table 141. Jiangsu Kanion Pharmaceutical Description and Business Overview
Table 142. Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Product
Table 144. Jiangsu Kanion Pharmaceutical Recent Developments/Updates
Table 145. Tianjin Pacific Pharmaceutical Company Information
Table 146. Tianjin Pacific Pharmaceutical Description and Business Overview
Table 147. Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Product
Table 149. Tianjin Pacific Pharmaceutical Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Pediatric Psoriasis Treatment Distributors List
Table 153. Pediatric Psoriasis Treatment Customers List
Table 154. Pediatric Psoriasis Treatment Market Trends
Table 155. Pediatric Psoriasis Treatment Market Drivers
Table 156. Pediatric Psoriasis Treatment Market Challenges
Table 157. Pediatric Psoriasis Treatment Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pediatric Psoriasis Treatment
Figure 2. Global Pediatric Psoriasis Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pediatric Psoriasis Treatment Market Share by Type: 2024 & 2031
Figure 4. Topical Treatment Product Picture
Figure 5. Systemic Treatment Product Picture
Figure 6. Global Pediatric Psoriasis Treatment Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Pediatric Psoriasis Treatment Market Share by Application: 2024 & 2031
Figure 8. Psoriasis Vulgaris
Figure 9. Pustular Psoriasis
Figure 10. Erythrodermic Psoriasis
Figure 11. Arthropathic Psoriasis
Figure 12. Global Pediatric Psoriasis Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Pediatric Psoriasis Treatment Market Size (2020-2031) & (US$ Million)
Figure 14. Global Pediatric Psoriasis Treatment Sales (2020-2031) & (K Units)
Figure 15. Global Pediatric Psoriasis Treatment Average Price (US$/Unit) & (2020-2031)
Figure 16. Pediatric Psoriasis Treatment Report Years Considered
Figure 17. Pediatric Psoriasis Treatment Sales Share by Manufacturers in 2024
Figure 18. Global Pediatric Psoriasis Treatment Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Pediatric Psoriasis Treatment Players: Market Share by Revenue in Pediatric Psoriasis Treatment in 2024
Figure 20. Pediatric Psoriasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Pediatric Psoriasis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Pediatric Psoriasis Treatment Sales Market Share by Country (2020-2031)
Figure 23. North America Pediatric Psoriasis Treatment Revenue Market Share by Country (2020-2031)
Figure 24. United States Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Pediatric Psoriasis Treatment Sales Market Share by Country (2020-2031)
Figure 27. Europe Pediatric Psoriasis Treatment Revenue Market Share by Country (2020-2031)
Figure 28. Germany Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Pediatric Psoriasis Treatment Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Pediatric Psoriasis Treatment Revenue Market Share by Region (2020-2031)
Figure 35. China Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Pediatric Psoriasis Treatment Sales Market Share by Country (2020-2031)
Figure 43. Latin America Pediatric Psoriasis Treatment Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Pediatric Psoriasis Treatment Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Pediatric Psoriasis Treatment Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Pediatric Psoriasis Treatment by Type (2020-2031)
Figure 54. Global Revenue Market Share of Pediatric Psoriasis Treatment by Type (2020-2031)
Figure 55. Global Pediatric Psoriasis Treatment Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Pediatric Psoriasis Treatment by Application (2020-2031)
Figure 57. Global Revenue Market Share of Pediatric Psoriasis Treatment by Application (2020-2031)
Figure 58. Global Pediatric Psoriasis Treatment Price (US$/Unit) by Application (2020-2031)
Figure 59. Pediatric Psoriasis Treatment Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Global Pediatric Psoriasis Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pediatric Psoriasis Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Pediatric Psoriasis Treatment Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pediatric Psoriasis Treatment Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Pediatric Psoriasis Treatment Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Pediatric Psoriasis Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Pediatric Psoriasis Treatment Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Pediatric Psoriasis Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Pediatric Psoriasis Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pediatric Psoriasis Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pediatric Psoriasis Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Pediatric Psoriasis Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pediatric Psoriasis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Psoriasis Treatment as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pediatric Psoriasis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Pediatric Psoriasis Treatment Sales by Region (2020-2025) & (K Units)
Table 18. Global Pediatric Psoriasis Treatment Sales Market Share by Region (2020-2025)
Table 19. Global Pediatric Psoriasis Treatment Sales by Region (2026-2031) & (K Units)
Table 20. Global Pediatric Psoriasis Treatment Sales Market Share by Region (2026-2031)
Table 21. Global Pediatric Psoriasis Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Pediatric Psoriasis Treatment Revenue Market Share by Region (2020-2025)
Table 23. Global Pediatric Psoriasis Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Pediatric Psoriasis Treatment Revenue Market Share by Region (2026-2031)
Table 25. North America Pediatric Psoriasis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Pediatric Psoriasis Treatment Sales by Country (2020-2025) & (K Units)
Table 27. North America Pediatric Psoriasis Treatment Sales by Country (2026-2031) & (K Units)
Table 28. North America Pediatric Psoriasis Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Pediatric Psoriasis Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Pediatric Psoriasis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Pediatric Psoriasis Treatment Sales by Country (2020-2025) & (K Units)
Table 32. Europe Pediatric Psoriasis Treatment Sales by Country (2026-2031) & (K Units)
Table 33. Europe Pediatric Psoriasis Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Pediatric Psoriasis Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Pediatric Psoriasis Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Pediatric Psoriasis Treatment Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Pediatric Psoriasis Treatment Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Pediatric Psoriasis Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Pediatric Psoriasis Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pediatric Psoriasis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Pediatric Psoriasis Treatment Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Pediatric Psoriasis Treatment Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Pediatric Psoriasis Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pediatric Psoriasis Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Pediatric Psoriasis Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Pediatric Psoriasis Treatment Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Pediatric Psoriasis Treatment Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Pediatric Psoriasis Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Pediatric Psoriasis Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Pediatric Psoriasis Treatment Sales (K Units) by Type (2020-2025)
Table 51. Global Pediatric Psoriasis Treatment Sales (K Units) by Type (2026-2031)
Table 52. Global Pediatric Psoriasis Treatment Sales Market Share by Type (2020-2025)
Table 53. Global Pediatric Psoriasis Treatment Sales Market Share by Type (2026-2031)
Table 54. Global Pediatric Psoriasis Treatment Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Pediatric Psoriasis Treatment Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Pediatric Psoriasis Treatment Revenue Market Share by Type (2020-2025)
Table 57. Global Pediatric Psoriasis Treatment Revenue Market Share by Type (2026-2031)
Table 58. Global Pediatric Psoriasis Treatment Price (US$/Unit) by Type (2020-2025)
Table 59. Global Pediatric Psoriasis Treatment Price (US$/Unit) by Type (2026-2031)
Table 60. Global Pediatric Psoriasis Treatment Sales (K Units) by Application (2020-2025)
Table 61. Global Pediatric Psoriasis Treatment Sales (K Units) by Application (2026-2031)
Table 62. Global Pediatric Psoriasis Treatment Sales Market Share by Application (2020-2025)
Table 63. Global Pediatric Psoriasis Treatment Sales Market Share by Application (2026-2031)
Table 64. Global Pediatric Psoriasis Treatment Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Pediatric Psoriasis Treatment Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Pediatric Psoriasis Treatment Revenue Market Share by Application (2020-2025)
Table 67. Global Pediatric Psoriasis Treatment Revenue Market Share by Application (2026-2031)
Table 68. Global Pediatric Psoriasis Treatment Price (US$/Unit) by Application (2020-2025)
Table 69. Global Pediatric Psoriasis Treatment Price (US$/Unit) by Application (2026-2031)
Table 70. AbbVie Company Information
Table 71. AbbVie Description and Business Overview
Table 72. AbbVie Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. AbbVie Pediatric Psoriasis Treatment Product
Table 74. AbbVie Recent Developments/Updates
Table 75. Amgen Company Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Amgen Pediatric Psoriasis Treatment Product
Table 79. Amgen Recent Developments/Updates
Table 80. Johnson and Johnson Company Information
Table 81. Johnson and Johnson Description and Business Overview
Table 82. Johnson and Johnson Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Johnson and Johnson Pediatric Psoriasis Treatment Product
Table 84. Johnson and Johnson Recent Developments/Updates
Table 85. Novartis AG Company Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Novartis AG Pediatric Psoriasis Treatment Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. Eli Lilly and Company Company Information
Table 91. Eli Lilly and Company Description and Business Overview
Table 92. Eli Lilly and Company Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Eli Lilly and Company Pediatric Psoriasis Treatment Product
Table 94. Eli Lilly and Company Recent Developments/Updates
Table 95. AstraZeneca Company Information
Table 96. AstraZeneca Description and Business Overview
Table 97. AstraZeneca Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. AstraZeneca Pediatric Psoriasis Treatment Product
Table 99. AstraZeneca Recent Developments/Updates
Table 100. Celgene Corporation Company Information
Table 101. Celgene Corporation Description and Business Overview
Table 102. Celgene Corporation Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Celgene Corporation Pediatric Psoriasis Treatment Product
Table 104. Celgene Corporation Recent Developments/Updates
Table 105. UCB Company Information
Table 106. UCB Description and Business Overview
Table 107. UCB Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. UCB Pediatric Psoriasis Treatment Product
Table 109. UCB Recent Developments/Updates
Table 110. Merck Company Information
Table 111. Merck Description and Business Overview
Table 112. Merck Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Merck Pediatric Psoriasis Treatment Product
Table 114. Merck Recent Developments/Updates
Table 115. Boehringer Ingelheim Company Information
Table 116. Boehringer Ingelheim Description and Business Overview
Table 117. Boehringer Ingelheim Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Boehringer Ingelheim Pediatric Psoriasis Treatment Product
Table 119. Boehringer Ingelheim Recent Developments/Updates
Table 120. LEO Pharma Company Information
Table 121. LEO Pharma Description and Business Overview
Table 122. LEO Pharma Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. LEO Pharma Pediatric Psoriasis Treatment Product
Table 124. LEO Pharma Recent Developments/Updates
Table 125. Qingdao Vland Biotech Company Information
Table 126. Qingdao Vland Biotech Description and Business Overview
Table 127. Qingdao Vland Biotech Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Qingdao Vland Biotech Pediatric Psoriasis Treatment Product
Table 129. Qingdao Vland Biotech Recent Developments/Updates
Table 130. Yunnan Botanee Bio-Technology Company Information
Table 131. Yunnan Botanee Bio-Technology Description and Business Overview
Table 132. Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Yunnan Botanee Bio-Technology Pediatric Psoriasis Treatment Product
Table 134. Yunnan Botanee Bio-Technology Recent Developments/Updates
Table 135. Furen Group Company Information
Table 136. Furen Group Description and Business Overview
Table 137. Furen Group Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Furen Group Pediatric Psoriasis Treatment Product
Table 139. Furen Group Recent Developments/Updates
Table 140. Jiangsu Kanion Pharmaceutical Company Information
Table 141. Jiangsu Kanion Pharmaceutical Description and Business Overview
Table 142. Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Jiangsu Kanion Pharmaceutical Pediatric Psoriasis Treatment Product
Table 144. Jiangsu Kanion Pharmaceutical Recent Developments/Updates
Table 145. Tianjin Pacific Pharmaceutical Company Information
Table 146. Tianjin Pacific Pharmaceutical Description and Business Overview
Table 147. Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Tianjin Pacific Pharmaceutical Pediatric Psoriasis Treatment Product
Table 149. Tianjin Pacific Pharmaceutical Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Pediatric Psoriasis Treatment Distributors List
Table 153. Pediatric Psoriasis Treatment Customers List
Table 154. Pediatric Psoriasis Treatment Market Trends
Table 155. Pediatric Psoriasis Treatment Market Drivers
Table 156. Pediatric Psoriasis Treatment Market Challenges
Table 157. Pediatric Psoriasis Treatment Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 161. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pediatric Psoriasis Treatment
Figure 2. Global Pediatric Psoriasis Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pediatric Psoriasis Treatment Market Share by Type: 2024 & 2031
Figure 4. Topical Treatment Product Picture
Figure 5. Systemic Treatment Product Picture
Figure 6. Global Pediatric Psoriasis Treatment Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Pediatric Psoriasis Treatment Market Share by Application: 2024 & 2031
Figure 8. Psoriasis Vulgaris
Figure 9. Pustular Psoriasis
Figure 10. Erythrodermic Psoriasis
Figure 11. Arthropathic Psoriasis
Figure 12. Global Pediatric Psoriasis Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Pediatric Psoriasis Treatment Market Size (2020-2031) & (US$ Million)
Figure 14. Global Pediatric Psoriasis Treatment Sales (2020-2031) & (K Units)
Figure 15. Global Pediatric Psoriasis Treatment Average Price (US$/Unit) & (2020-2031)
Figure 16. Pediatric Psoriasis Treatment Report Years Considered
Figure 17. Pediatric Psoriasis Treatment Sales Share by Manufacturers in 2024
Figure 18. Global Pediatric Psoriasis Treatment Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Pediatric Psoriasis Treatment Players: Market Share by Revenue in Pediatric Psoriasis Treatment in 2024
Figure 20. Pediatric Psoriasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Pediatric Psoriasis Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Pediatric Psoriasis Treatment Sales Market Share by Country (2020-2031)
Figure 23. North America Pediatric Psoriasis Treatment Revenue Market Share by Country (2020-2031)
Figure 24. United States Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Pediatric Psoriasis Treatment Sales Market Share by Country (2020-2031)
Figure 27. Europe Pediatric Psoriasis Treatment Revenue Market Share by Country (2020-2031)
Figure 28. Germany Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Pediatric Psoriasis Treatment Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Pediatric Psoriasis Treatment Revenue Market Share by Region (2020-2031)
Figure 35. China Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Pediatric Psoriasis Treatment Sales Market Share by Country (2020-2031)
Figure 43. Latin America Pediatric Psoriasis Treatment Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Colombia Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Pediatric Psoriasis Treatment Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Pediatric Psoriasis Treatment Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Pediatric Psoriasis Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Pediatric Psoriasis Treatment by Type (2020-2031)
Figure 54. Global Revenue Market Share of Pediatric Psoriasis Treatment by Type (2020-2031)
Figure 55. Global Pediatric Psoriasis Treatment Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Pediatric Psoriasis Treatment by Application (2020-2031)
Figure 57. Global Revenue Market Share of Pediatric Psoriasis Treatment by Application (2020-2031)
Figure 58. Global Pediatric Psoriasis Treatment Price (US$/Unit) by Application (2020-2031)
Figure 59. Pediatric Psoriasis Treatment Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Household Embroidery Machines Market Research Report 2025
Jul 18, 25
Global Residential Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Global Commercial Electric Underfloor Heating Market Research Report 2025
Jul 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232